Human-Computer Interaction Resource Network
| Accueil : Biotech Finances | |
| Biotech Finances est une lettre profesionnelle Hebdomadaire francophone et une webTV sur l | |
| Keywords : Editions Europ | |
| H2 tags : Sommaire n |
| Last Update : | 14/December/2011 |
| Google PR : | 5 |
| Internal links : | 42 |
| External links : | 9 |
| Archive : | Check how did the site look in the past? |
| Keyword | Occurrences | Percentage |
|---|---|---|
| des | 24 | 1.86% |
| biotech | 23 | 1.78% |
| les | 20 | 1.55% |
| finances | 17 | 1.32% |
| lire | 14 | 1.08% |
| Keyword | Occurrences | Percentage |
|---|---|---|
| biotech finances | 17 | 2.63% |
| la suite | 14 | 2.17% |
| lire la | 14 | 2.17% |
| et les | 5 | 0.77% |
| d veloppement | 5 | 0.77% |
| Keyword | Occurrences | Percentage |
|---|---|---|
| lire la suite | 14 | 3.25% |
| de la vie | 3 | 0.70% |
| le billet bio | 3 | 0.70% |
| sciences de la | 3 | 0.70% |
| des sciences de | 3 | 0.70% |
| Site IP address : | 94.23.33.78 |
| Server type : | Apache/2.2.8 (Ubuntu) mod_ssl/2.2.8 OpenSSL/0.9.8g |
| Powered by : | PHP/5.2.4-2ubuntu5.9 |
| DNS 1 : | ns6.gandi.net |
| DNS 2 : | web-1.biotech-finances.com |
| MX Domain 1 : | web-1.biotech-finances.com |
| Alexa rank : | 2,857,529 |
| Description : | Biotech-finances.com's three-month global Alexa traffic rank is 2,857,529. Roughly 70% of visits to the site are bounces (one pageview only). Visitors to the site view 1.3 unique pages each day on average. Roughly 20% of visits to Biotech-finances.com are referred by search engines. It has been online for more than six years. |
| natural plant protection | 4.54% |
| panitumumab | 3.30% |
| 2798 biopep | 2.29% |
| aapm sur | 1.87% |
| assurance & capital partners | 1.85% |
| irt lyon biotech jacques berger | 1.51% |
| gérard tiraby | 1.44% |
| bio tech mach | 1.37% |
| biotech bourse | 1.34% |
| biosourcing europe | 1.34% |
| Quantcast rank : | 0 | Average US daily traffic : | 0 |
| Compete rank : | 0 |
| Average daily unique visitors : | 0 |
| MyWot rank : | 0 |
| Trustworthiness : | 0 |
| Vendor reliability : | 0 |
| Privacy : | 0 |
| Child safety : | 0 |
|
|
|
|
|
|